Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Market Cap : 1.028B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.028B |
| August 21, 2026 | 1.030B |
| August 20, 2026 | 942.71M |
| August 19, 2026 | 984.22M |
| August 18, 2026 | 956.55M |
| August 17, 2026 | 930.86M |
| August 14, 2026 | 922.95M |
| August 13, 2026 | 905.16M |
| August 12, 2026 | 907.14M |
| August 11, 2026 | 922.95M |
| August 10, 2026 | 907.14M |
| August 07, 2026 | 915.05M |
| August 06, 2026 | 894.14M |
| August 05, 2026 | 909.90M |
| August 04, 2026 | 870.51M |
| August 03, 2026 | 858.69M |
| July 31, 2026 | 854.75M |
| July 30, 2026 | 868.54M |
| July 29, 2026 | 844.91M |
| July 28, 2026 | 868.54M |
| July 27, 2026 | 868.54M |
| July 24, 2026 | 862.63M |
| July 23, 2026 | 880.36M |
| July 22, 2026 | 852.78M |
| July 21, 2026 | 890.20M |
| Date | Value |
|---|---|
| July 20, 2026 | 868.54M |
| July 17, 2026 | 898.08M |
| July 16, 2026 | 933.53M |
| July 15, 2026 | 898.08M |
| July 14, 2026 | 907.93M |
| July 13, 2026 | 918.76M |
| July 10, 2026 | 945.35M |
| July 09, 2026 | 1.012B |
| July 08, 2026 | 1.028B |
| July 07, 2026 | 1.020B |
| July 06, 2026 | 978.83M |
| July 02, 2026 | 959.14M |
| July 01, 2026 | 931.56M |
| June 30, 2026 | 945.35M |
| June 29, 2026 | 921.72M |
| June 26, 2026 | 902.02M |
| June 25, 2026 | 868.54M |
| June 24, 2026 | 878.39M |
| June 23, 2026 | 876.42M |
| June 22, 2026 | 890.20M |
| June 18, 2026 | 896.11M |
| June 17, 2026 | 872.48M |
| June 16, 2026 | 864.60M |
| June 15, 2026 | 850.81M |
| June 12, 2026 | 839.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 55.42B |
| Insmed, Inc. | 27.06B |
| Pfizer Inc. | 159.40B |
| Gossamer Bio, Inc. | 85.55M |
| Legend Biotech Corp. | 4.058B |
Market Cap Related Metrics
| PE Ratio | 6.638 |
| PS Ratio | 5.558 |
| Price to Book Value | 3.972 |
| Price | 5.20 |
| Earnings Yield | 15.07% |
| Operating PE Ratio | 6.851 |
| Normalized PE Ratio | 6.687 |